Hepatitis, Chronic
Showing 51 - 75 of >10,000
Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)
Not yet recruiting
- Chronic Hepatitis B
- PEG IFN α-2b; TAF
- (no location specified)
Aug 5, 2022
HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))
Recruiting
- HBV Infection
- Chronic Hepatitis b
- Tenofovir Amibufenamide(TMF)
-
Beijing, China
- +11 more
Mar 22, 2023
Chronic Hepatitis b Trial in Guangzhou (Vitamin D)
Completed
- Chronic Hepatitis b
- Vitamin D
-
Guangzhou, Guangdong, ChinaDepartment of Infectious Diseases, The Third Affliated Hospital
Mar 2, 2023
Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene
Recruiting
- Hepatitis B, Chronic
- genotyping
-
Sohag, EgyptSohag university Hospital
Sep 4, 2023
Chronic Hepatitis b Trial in Beijing (ASC22, sodium chloride)
Active, not recruiting
- Chronic Hepatitis b
- ASC22
- sodium chloride
-
Beijing, ChinaPeking University First Hospital
Jul 18, 2022
Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)
Completed
- Chronic Hepatitis c Genotype 1
- Narlaprevir
- +2 more
-
Moscow, Russian Federation
- +4 more
Oct 27, 2022
Chronic Hepatitis B Trial (Bepirovirsen, Placebo)
Recruiting
- Chronic Hepatitis B
- Bepirovirsen
- Placebo
-
Herston, Queensland, Australia
- +7 more
Jan 23, 2023
Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined
Recruiting
- Hepatocellular Carcinoma
- Chronic Hepatitis B
- NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined with interferon treatments
- NAs ("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") treatments
-
Xiamen, Fujian, ChinaBoheng Zhang
Feb 7, 2023
Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)
Terminated
- Chronic Hepatitis C
- 20mg ezetimibe
- +2 more
-
Hines, IllinoisEdward Hines Jr. VA Hospital, Hines, IL
May 10, 2022
Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)
Recruiting
- Chronic Hepatitis B Virus Infection
- Ropeginterferon alfa-2b
- Entecavir
-
Kaohsiung, Taiwan
- +4 more
Aug 12, 2022
Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)
Recruiting
- Chronic Hepatitis B
- Bepirovirsen
- Placebo
-
Victoria, British Columbia, Canada
- +10 more
Jan 23, 2023
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
Chronic Hepatitis B, High-Risk Cancer Trial in China (Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide
Active, not recruiting
- Chronic Hepatitis B
- High-Risk Cancer
- Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue
- Nucleos(t)ide analogue
-
Chengdu, China
- +8 more
Jan 4, 2023
Chronic Hepatitis B, Hepatic Fibrosis, Fatty Liver Trial in Seoul
Active, not recruiting
- Chronic Hepatitis B
- +2 more
-
Seoul, Korea, Republic ofSeoul Metropolitan Government Seoul National University
May 3, 2022
Steatohepatitis in Chronic Hepatitis B
Completed
- Fatty Liver
- Chronic Hepatitis b
- Antiviral Agents
-
Bangkoknoi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital
Mar 30, 2022
Novel Simplified Score for Chronic Hepatitis B Treatment
Not yet recruiting
- Chronic Hepatitis B
- TREAT-B score
-
Bangkok, ThailandSiriraj Hospital
Apr 1, 2022
Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)
Recruiting
- Hepatitis B, Chronic
- AHB-137 injection
- Placebo
-
Jilin, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))
Withdrawn
- Chronic Hepatitis B
- hepatitis B immune globulin (HBIg)
- Pegylated interferon alfa (pegIFN)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 4, 2022
Hepatitis B Trial in Cambridge (GSK3965193, Placebo to match GSK3965193, Bepirovirsen)
Recruiting
- Hepatitis B
- GSK3965193
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Jun 14, 2022
System of Clinical Endpoint Events for Chronic Hepatitis B
Active, not recruiting
- Chronic Hepatitis b
-
Beijing, Beijing, China
- +6 more
Sep 2, 2022
A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX
Recruiting
- Hepatitis C
-
Istanbul, TurkeyCerrahpasa Medical Faculty
Aug 26, 2023
Hepatitis D Trial in Athens (Bulevirtide)
Recruiting
- Hepatitis D
-
Athens, GreeceDepartment of Gastroenterology, Medical School of National & Kap
Jun 28, 2023
Chronic Hepatitis B Trial in Auckland (TAF, TDF, Other approved antivirals)
HBsAg Declined Patients Follow-up Study
Not yet recruiting
- Hepatitis B
- Hepatitis B, Chronic
- (no location specified)
Jul 28, 2023